Article info

Download PDFPDF

Protease inhibition as new therapeutic strategy for GI diseases


  • Nathalie Vergnolle Inserm, U1220, Toulouse, France Université de Toulouse, Université Paul Sabatier, Institut de Recherche en Santé Digestive (IRSD), Toulouse, France Inra, U1416, Toulouse, France Ecole Nationale Vétérinaire de Toulouse (ENVT), France Department of Pharmacology and Physiology, University of Calgary, Calgary, Alberta, Canada PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Nathalie Vergnolle, INSERM, UMR-1220, IRSD, Place du Dr. Baylac, CHU Purpan, CS 60039, Toulouse 31024, Cedex 3, France; nathalie.vergnolle{at}
View Full Text


Vergnolle N
Protease inhibition as new therapeutic strategy for GI diseases

Publication history

  • Received April 3, 2015
  • Revised February 5, 2016
  • Accepted February 12, 2016
  • First published April 12, 2016.
Online issue publication 
June 03, 2016

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.